Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sukanya Raghavan

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cellsJia-Bin Sun, Sukanya Raghavan, Asa Sjöling, et al.
Infection and Immunity|February 27, 2013
A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infectionLouise Sjökvist Ottsjö, Carl-Fredrik Flach, John Clements, et al.
Vaccine|August 19, 2018
Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvantJan Holmgren, Stefan Nordqvist, Margareta Blomquist, et al.
Plos One|October 4, 2011
CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitisYu-Yuan C Götlind, Sukanya Raghavan, Paul W Bland, et al.
Vaccine|December 15, 2010
A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pyloriCarl-Fredrik Flach, Natascha Svensson, Margareta Blomquist, et al.
Oncoimmunology|February 12, 2024
Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancerPatrik Sundström, Nikita Dutta, William Rodin, et al.
Cytokine|July 7, 2017
Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptomsJenni Adamsson, Louise Sjökvist Ottsjö, Samuel B Lundin, et al.
BMC Immunology|August 7, 2013
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patientsJennifer Pieper, Jessica Herrath, Sukanya Raghavan, et al.
Immunology|September 28, 2016
Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunizationLouise Sjökvist Ottsjö, Frida Jeverstam, Linda Yrlid, et al.
Infection and Immunity|November 17, 2010
Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phaseCarl-Fredrik Flach, Anna Karin Östberg, Anne-Therese Nilsson, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cellsJia-Bin Sun, Sukanya Raghavan, Asa Sjöling, et al.
Infection and Immunity|February 27, 2013
A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infectionLouise Sjökvist Ottsjö, Carl-Fredrik Flach, John Clements, et al.
Vaccine|August 19, 2018
Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvantJan Holmgren, Stefan Nordqvist, Margareta Blomquist, et al.
Plos One|October 4, 2011
CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitisYu-Yuan C Götlind, Sukanya Raghavan, Paul W Bland, et al.
Vaccine|December 15, 2010
A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pyloriCarl-Fredrik Flach, Natascha Svensson, Margareta Blomquist, et al.
Oncoimmunology|February 12, 2024
Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancerPatrik Sundström, Nikita Dutta, William Rodin, et al.
Cytokine|July 7, 2017
Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptomsJenni Adamsson, Louise Sjökvist Ottsjö, Samuel B Lundin, et al.
BMC Immunology|August 7, 2013
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patientsJennifer Pieper, Jessica Herrath, Sukanya Raghavan, et al.
Immunology|September 28, 2016
Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunizationLouise Sjökvist Ottsjö, Frida Jeverstam, Linda Yrlid, et al.
Infection and Immunity|November 17, 2010
Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phaseCarl-Fredrik Flach, Anna Karin Östberg, Anne-Therese Nilsson, et al.
Pageof 5